Results 151 to 160 of about 1,042 (177)
Some of the next articles are maybe not open access.
Use of Nemolizumab in Refractory Scrotal Dysesthesia
JAMA DermatologyThis case report describes 2 patients with refractory scrotal dysesthesia treated with nemolizumab.
openaire +1 more source
Anti-IL-31 receptor alpha monoclonal antibody: Nemolizumab
Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology, 2023Hiroshi Matsuzaki, Hiroshi Odajima
openaire +1 more source
Nemolizumab decreases lesions and itch in prurigo nodularis
Medicom Conference Report AAD 2023, 2023Shawn Kwatra, Susanne Kammerer
openaire +1 more source
Nemolizumab‐induced exacerbation of atopic dermatitis
The Journal of DermatologyHirofumi Kamada +6 more
openaire +2 more sources
Nemolizumab shows high success rates in prurigo nodularis
Medicom Conference Report EADV 2023, 2023openaire +1 more source
Nemolizumab reduziert Juckreiz bei Atopischer Dermatitis
Aktuelle Dermatologie, 2017openaire +1 more source
A case of bullous pemphigoid after nemolizumab administration
The Journal of DermatologyYuriko Ishikawa, Ken Washio
openaire +2 more sources
Nemolizumab to target the itch–scratch cycle in paediatric atopic dermatitis
British Journal of Dermatology, 2023openaire +2 more sources